SCHEMBL25090994

SCHEMBL25090994

CCc1cc(-c2cc(C(=O)N3CC[C@@H](C(=O)NCc4ncc(F)cc4C)CC34CC4)n[nH]2)c(F)cn1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ KDM5A P29375 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24424784 0.93 BACE1 (0.34) KDM5A
SCHEMBL29243373 0.93 BACE1 (0.34) KDM5A
SCHEMBL24424783 0.93 BACE1 (0.34) KDM5A
SCHEMBL24424311 0.90 CHEK1 (0.33) KDM5A
SCHEMBL29584737 0.90 CHEK1 (0.33) KDM5A
SCHEMBL29243488 0.86 MAPK1 (0.39) KDM5A
SCHEMBL29585608 0.86 MAPK1 (0.39) KDM5A
SCHEMBL25090915 0.86 MAPK1 (0.39) KDM5A
SCHEMBL25090914 0.86 MAPK1 (0.39) KDM5A
SCHEMBL25090908 0.84 CHEK1 (0.33) KDM5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230062861-A1 PPARg MODULATORS AND METHODS OF USE EISAI R&D MANAGEMENT CO., LTD. (JP) 2023-03-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230062861-A1 PPARg MODULATORS AND METHODS OF USE PPARG, PPARA, PPARD KDM5A 4027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback